drugset / Trial / NCT06947746

HiSCs in the Treatment of Rheumatoid Arthritis

NCT06947746 ↗

Recruiting 15 enrolled Shanghai Changzheng Hospital
NaSingle-groupOpen-labelTreatment

Summary

This trial is a single-center, single-arm exploratory clinical study aimed at assessing the safety, tolerability, and preliminary efficacy of a single intra-articular injection of hiSCs for the treatment of rheumatoid arthritis.

Timeline

Start
2025-05-01
Primary completion
2026-06-01
Completion
2027-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject hiSCs Unknown — Other

Indications